GLOBUS MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
GLOBUS MEDICAL, INC. (GMED) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.21% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2026-08-06
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2026-03-31 was 3.87%, a 14.38% decline year-over-year.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2025-03-31 was 4.52%, a 3.91% increase year-over-year.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-03-31 was 4.35%, a 6.10% increase year-over-year.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2023-03-31 was 4.10%, a 110.26% increase year-over-year.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2025 was 4.52%, a 4.84% decline from fiscal 2024.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.75%, a 0.42% decline from fiscal 2023.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 4.77%, a 18.07% increase from fiscal 2022.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 4.04%, a 254.39% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.21% 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 3.87% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 4.52% 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 4.52% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 4.52% 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 4.52% 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 4.75% 10-K · filed 2026-02-24 | |||
| 2024-09-30 | 4.75% 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 4.74% 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 4.35% 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 4.77% 10-K · filed 2026-02-24 | |||
| 2023-09-30 | 4.45% 10-Q · filed 2024-11-05 | |||
| 2023-06-30 | 4.10% 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | 4.10% 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | 4.04% 10-K · filed 2025-02-20 | |||
| 2022-09-30 | 3.51% 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | 3.36% 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | 1.95% 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | 1.14% 10-K · filed 2024-02-21 | |||
| 2021-09-30 | 0.84% 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | 0.84% 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | 0.81% 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | 1.67% 10-K · filed 2023-02-21 | |||
| 2020-09-30 | 1.67% 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | 1.67% 10-Q · filed 2021-08-04 | |||
| 2020-03-31 | 1.67% 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | 2.57% 10-K · filed 2022-02-17 | |||
| 2018-12-31 | 3.09% 10-K · filed 2021-02-17 | |||
| 2017-12-31 | 2.20% 10-K · filed 2019-02-21 | |||
| 2016-12-31 | 2.01% 10-K · filed 2019-02-21 | |||
| 2015-12-31 | 2.11% 10-K · filed 2018-02-22 | |||
| 2014-12-31 | 1.95% 10-K · filed 2017-03-16 | |||
| 2013-12-31 | 1.74% 10-K · filed 2016-02-29 | |||
| 2012-12-31 | 1.10% 10-K · filed 2015-02-26 | |||
| 2011-12-31 | 2.65% 10-K · filed 2014-03-14 | |||
| 2010-12-31 | 2.64% 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |